Mushidur Rahman | Echocardiography | Best Researcher Award

Published on by Cardiology and Cardiovascular Medicine

Dr. Mushidur Rahman | Echocardiography | Best Researcher Award

Dr. Mushidur Rahman, Coventry University, United Kingdom

Dr. Mushidur Rahman is a UK-based Clinical Cardiovascular Physiologist and PhD candidate at Coventry University. With accreditation from the British Society of Echocardiography, he specializes in advanced echocardiographic imaging and cardiac diagnostics. He holds an MSc in Translational Cardiovascular Medicine from the University of Bristol and a BSc in Cardiac Physiology. Currently an Advanced Cardiac Physiologist at Sandwell and West Birmingham Hospitals, he also lectures at Coventry University. Passionate about improving patient care through research and education, Dr. Rahman combines clinical expertise with academic insight to advance the field of cardiovascular diagnostics and healthcare quality.

AUTHOR PROFILE

Scopus Profile

Orcid Profile

👨‍🎓 EARLY ACADEMIC PURSUITS:

Dr. Mushidur Rahman’s academic journey showcases a deep-rooted passion for cardiovascular sciences. He began with a GCSE foundation at Park View School in 2008, where he excelled in subjects like Religious Studies (A) and Mathematics (B), and demonstrated broad intellectual interest across humanities and sciences.
He further pursued A-Levels and a BTEC in Applied Science at Midlands Metropolitan College (2012), achieving a Distinction-Merit in BTEC, and a solid grounding in Law, Sociology, and Psychology.

His academic focus intensified with a BSc (Hons) in Cardiac Physiology from the University of Wolverhampton in 2015, laying the clinical and scientific groundwork in cardiology. In 2019, he earned an MSc in Translational Cardiovascular Medicine from the University of Bristol, a program that bridged laboratory science with clinical applications. He is currently finalizing his Ph.D. in Clinical Cardiovascular Physiology at Coventry University, with expected completion in 2025.

🏥 PROFESSIONAL ENDEAVORS:

Dr. Rahman brings nearly a decade of clinical experience in NHS settings, blending expert-level echocardiography with leadership in cardiac services.

🔬 ADVANCED CARDIAC PHYSIOLOGIST:

Sandwell and West Birmingham Hospitals NHS Trust (2016–Present)
He has served as an Advanced Cardiac Physiologist specializing in echocardiography, while also acting as Deputy Lead in the Cardiac Catheterisation Lab. His responsibilities include:

  • Supervising and mentoring junior staff and students 👨‍⚕️

  • Conducting audits and clinical research

  • Collaborating closely with cardiologist consultants

  • Leading multidisciplinary team (MDT) meetings

  • Supporting IQIPS (Improving Quality in Physiological Services) objectives

👨‍🏫 VISITING LECTURER:

Coventry University (2022–Present)
As an academic contributor under the Associate Fellowship for Higher Education, Dr. Rahman has lectured on Cardio-Respiratory anatomy and physiology across BSc Paramedic Science and Nursing programs. He provides practical demonstrations and life support training, enriching student experiences with real-world insight.

🩺 EARLY CLINICAL EXPERIENCE:

Heart of England NHS Trust (Jan–Jul 2016)
His early role as a Cardiac Physiologist involved:

  • Performing and analyzing ECGs and exercise tolerance tests

  • Involvement in the cardiac catheter laboratory

  • Conducting pacemaker follow-up clinics

  • Participating in on-call services for cardiac emergencies

🧪 CONTRIBUTIONS AND RESEARCH FOCUS ON ECHOCARDIOGRAPHY:

Dr. Rahman’s research focuses on diagnostic cardiac imaging, echocardiographic techniques, and cardiovascular physiology. His work aims to improve:

  • Diagnostic accuracy

  • Early detection of cardiac pathologies

  • Evidence-based approaches in patient management

He is also active in clinical audits and quality improvement initiatives, tying his academic research directly to patient outcomes and healthcare efficiency.

🌍 IMPACT AND INFLUENCE:

Dr. Rahman’s dual roles in clinical practice and academia allow him to influence both current patient care and the future generation of healthcare professionals. His leadership in MDT meetings and mentorship of junior staff contribute to a collaborative and learning-centered environment.

Through public speaking, teaching, and research dissemination, he promotes a patient-centric model of care in cardiology, focused on compassion, precision, and innovation.

📚 ACADEMIC CITES & PROFESSIONAL ACCREDITATION:

  • Accredited by the British Society of Echocardiography (BSE)

  • Active contributor to clinical research publications and audits

  • Pursuing doctoral research that may contribute to peer-reviewed journals, elevating standards in diagnostic cardiology

🌟 LEGACY AND FUTURE CONTRIBUTIONS:

Dr. Rahman’s career trajectory is guided by a clear vision: to bridge the gap between academic innovation and clinical excellence in cardiovascular medicine. In the future, he aims to:

  • Publish impactful research in top cardiology journals

  • Lead national or international quality improvement programs

  • Develop training modules for cardiac physiologists and clinicians

  • Promote patient-centered care through policy and practice enhancements

His commitment to lifelong learning and multidisciplinary collaboration ensures his continued positive influence in cardiology and healthcare education.

✨CONCLUSION:

Dr. Mushidur Rahman is a dedicated cardiovascular professional, blending clinical expertise with academic pursuit. His passion for advancing cardiac diagnostics through echocardiography and clinical research is evident in his work at Sandwell and West Birmingham Hospitals and his role as a lecturer at Coventry University. Accredited by the British Society of Echocardiography, he strives to make a significant impact on patient care and healthcare quality. With a commitment to lifelong learning, Dr. Rahman is shaping the future of cardiovascular medicine through both his clinical practice and research contributions.

TOP NOTABLE PUBLICATIONS

Title: Relationship between heart rate variability and echocardiography indices of cardiac function in healthy individuals
Authors: Rahman, M., Russell, S.L., Okwose, N.C., Banerjee, P., Jakovljević, D.G.
Journal: Clinical Physiology and Functional Imaging
Year: 2025

Title: Validity and reliability of short‐term heart‐rate variability from disposable electrocardiography leads
Authors: Rahman, M.
Journal: Health Science Reports
Year: 2023

Title: Association between pulse wave velocity and measures of cardiac function in healthy individuals
Authors: Rahman, M.
Journal: Heart Journal
Year: 2022

Title: Relationship between cardiac autonomic function and novel echocardiography indices of left ventricular function
Authors: Rahman, M.
Journal: Heart Journal
Year: 2022

Title: Observations on echocardiographic findings in patients with COVID-19
Authors: Rahman, M.
Year: 2020

Jian-Jun Li | Cardiology | Best Researcher Award

Published on by Cardiology and Cardiovascular Medicine

Prof. Dr. Jian-Jun Li | Cardiology | Best Researcher Award

Prof. Dr. Jian-Jun Li, Fuwai hospital, China

Prof. Dr. Jian-Jun Li is a renowned cardiologist at Fu Wai Hospital, Chinese Academy of Medical Science, Beijing. He holds an MD from Wuhan University, a PhD from Kyushu University, Japan, and completed post-doctoral training in the USA. As Professor and Consultant at the Cardiometabolic Center, his research focuses on dyslipidemia, inflammation, atherosclerosis, and interventional cardiology. He serves as Vice President of the Chinese Molecular College of Cardiology and is a national expert in cardiovascular disease prevention. Prof. Li has received multiple prestigious science awards, recognizing his significant contributions to cardiovascular medicine and public health in China.

AUTHOR PROFILE

Scopus Profile

👨‍🎓 EARLY ACADEMIC PURSUITS:

Prof. Dr. Jian-Jun Li began his academic journey in medicine at Wuhan University, China, where he pursued his MD from 1978 to 1986. With a strong foundation in clinical and theoretical medical sciences, he furthered his education with a PhD from Kyushu University, Japan (1991–1995)—a prestigious institution known for its cutting-edge biomedical research. He then expanded his international experience through a Post-doctoral Fellowship at the University of Louisville, USA (1995–1997), where he explored advanced cardiovascular research.

👨‍⚕️ PROFESSIONAL ENDEAVORS:

Currently, Prof. Dr. Jian-Jun Li serves as a Professor and Consultant at the Cardiometabolic Center, Fu Wai Hospital, affiliated with the Chinese Academy of Medical Science and Peking Union Medical College, Beijing. This esteemed role places him at the heart of China’s most influential medical and research institution for cardiovascular health.

In addition to his primary role:

  •  He is the Vice President of the Chinese Molecular College of Cardiology.

  •  He is a Member of the National Expert Committee on Prevention and Control of Cardiovascular Disease.

  •  He is an Expert Member of the Chinese Doctor Union.

🧪 CONTRIBUTIONS AND RESEARCH FOCUS ON CARDIOLOGY:

Prof. Dr. Jian-Jun Li’s research work is both broad and impactful, focusing on some of the most critical issues in modern cardiology:

  • Dyslipidemia – studying abnormal lipid levels and their role in cardiovascular disease.

  • Inflammation and Atherosclerosis – understanding how chronic inflammation contributes to plaque buildup in arteries.

  • Interventional Cardiology – innovating and improving minimally invasive procedures to treat cardiovascular conditions.

His work bridges the gap between molecular cardiology and clinical applications, aiming for preventive and therapeutic breakthroughs in cardiovascular health.

🏆 IMPACT AND INFLUENCE:

Prof. Li’s contributions have been nationally and internationally acknowledged:

  • Secondary Awards of National Science and Technology in Advance (2002)

  • Hubei Province Awards of Chinese Science and Technology in Advance for five consecutive years: 1999–2003

These awards reflect the consistency, excellence, and innovation in his work, particularly in translational medicine and cardiovascular disease control.

📚 ACADEMIC CITES AND COLLABORATIONS:

Prof. Li has been widely cited in national and international scientific publications. His peer-reviewed research articles in leading cardiology and internal medicine journals have significantly influenced clinical practices in China and abroad. His collaborations with researchers in Japan, the USA, and Europe have expanded the global reach of Chinese cardiovascular research.

🧬 LEGACY AND FUTURE CONTRIBUTIONS:

As a visionary academic and physician, Prof. Li’s legacy is cemented in:

  •  Mentoring the next generation of cardiologists and researchers in China.

  •  Shaping policy frameworks for cardiovascular disease prevention nationwide.

  •  Advancing personalized medicine approaches in dyslipidemia and atherosclerosis.

  •  Promoting international cooperation in cardiovascular research.

His future contributions are likely to continue influencing both clinical and molecular cardiology, especially in integrative therapeutic techniques and public health strategies.

🌟CONCLUSION:

Prof. Dr. Jian-Jun Li stands as a leading figure in the field of cardiology, combining clinical expertise with groundbreaking research. His contributions to understanding and treating dyslipidemia, inflammation, and atherosclerosis have advanced both preventive and interventional cardiology in China and beyond. Through his leadership roles and active participation in national health committees, he continues to influence cardiovascular disease prevention strategies. His dedication to medical science, mentorship, and innovation ensures a lasting legacy in improving heart health. Prof. Li’s work not only enhances clinical outcomes but also inspires the next generation of medical researchers and practitioners.

TOP NOTABLE PUBLICATIONS

Article: Association of Insomnia, Lipid Profile, and Lipid-Lowering Medications: A Narrative Review

Authors: Jia, Fang; Shi, Shunyi; Fei, Sifan; Zhou, Min; Li, Jianjun

Journal: Review

Article: Moderate-Intensity Statin Plus Ezetimibe: Time to Rethink it as an Optimal Initial Lipid-Lowering Strategy

Authors: Li, Sha; Liu, Huihui; Li, Jianjun

Journal: Review

Article: Tafolecimab, a Third Monoclonal Antibody for PCSK9 as the Novel Lipid-Lowering Drug Around the World: A Narrative Review

Authors: Liu, Huihui; Li, Sha; Li, Jianjun

Journal: Review

Article: The effect of lipid-lowering therapy on lipid-related residual risk factors: a prospective study

Authors: Li, Zhifan; Gao, Yanan; Lu, Qianhong; Qiu, Hong; Wu, Naqiong; Li, Jianjun

Journal: Lipids in Health and Disease

Year: 2024

Article: The Effects of Sacubitril/Valsartan Compared to Olmesartan on the Blood Pressure and Glucolipid Metabolism in DM Patients with Primary Hypertension

Authors: Zhang, Shuang; Yin, Zheng; Li, Zhifan; Qian, Jie; Wu, Naqiong; Li, Jianjun

Journal: Cardiovascular Drugs and Therapy

Year: 2024

Article: Twin Phenomena of Hypertrophic Cardiomyopathy: A Reported Case Series

Authors: Zeng, Jiangting; Zhang, Ying’ai; Ma, Tianyi; Zhong, Jianghua; Li, Jianjun

Journal: Review

Article: Prognostic role of lipoprotein(a) in atherosclerotic cardiovascular disease risk from a perspective on current risk stratification

Authors: Li, Sha; Liu, Huihui; Zhang, Yan; Guo, Yuanlin; Li, Jianjun

Journal: MedComm

Year: 2024

Editorial: Lipids, Genetics, and the Risk of Type 2 Diabetes: More Studies Needed to Uncover the Mysteries

Author: Li, Jianjun

Journal: Editorial

Article: Prognostic value of red blood cell distribution width-to-albumin ratio in patients with stable coronary artery disease stratified by glucose metabolic status: a prospective cohort study

Authors: Liu, Huihui; Guo, Yuanlin; Zhu, Chenggang; Qian, Jie; Li, Jianjun

Journal: Cardiology Plus

Year: 2024

Article: Lipoprotein(a) and ischemic stroke: current insights and knowledge gaps

Authors: Yang, Cheng; Wu, Yongjian; Qian, Jie; Li, Jianjun

Journal: Review

Ling He | Cardiotoxicity | Best Research Article Award

Published on by Cardiology and Cardiovascular Medicine

Assoc. Prof. Dr. Ling He | Cardiotoxicity | Best Research Article Award

Assoc. Prof. Dr. Ling He, The Second Affiliated Hospital of Nanchang University, China

Assoc. Prof. Dr. Ling He is a distinguished medical professional at The Second Affiliated Hospital of Nanchang University, China. With a strong background in clinical medicine, she specializes in translational research, innovative diagnostics, and patient-centered care. As an associate professor, she actively mentors medical students and leads research projects focused on improving clinical outcomes and healthcare quality. Her work has been published in reputed journals and widely cited, reflecting her influence in the medical research community. Dr. He remains committed to advancing healthcare practices through academic excellence, collaborative research, and continuous medical innovation.

AUTHOR PROFILE

Scopus Profile

🧠 EARLY ACADEMIC PURSUITS:

Assoc. Prof. Dr. Ling He began her academic journey with a strong foundation in medical sciences, developing an early interest in clinical medicine and healthcare research. She pursued her undergraduate and postgraduate studies in prestigious medical institutions in China, eventually specializing in fields aligned with clinical diagnosis, treatment innovation, and patient-centric research. Her commitment to academic excellence and scientific rigor laid the groundwork for a promising career in medical academia and clinical research.

🩺 PROFESSIONAL ENDEAVORS:

Dr. Ling He currently serves as an Associate Professor at The Second Affiliated Hospital of Nanchang University, one of China’s reputed medical research and teaching hospitals. In her role, she is deeply involved in clinical practice, academic instruction, and mentoring young medical professionals. Her position also includes collaboration with multidisciplinary teams to improve healthcare delivery and treatment outcomes. Over the years, she has participated in numerous research projects, contributing both as a principal investigator and a collaborator.

🔬 CONTRIBUTIONS AND RESEARCH FOCUS ON CARDIOTOXICITY:

Dr. Ling He’s research spans a range of clinical and biomedical sciences, focusing on:

  • Translational medicine

  • Clinical treatment protocols and their effectiveness

  • Patient safety and quality improvement in hospitals

  • Innovative diagnostic techniques

  • Public health and epidemiological studies

Her studies aim to bridge the gap between laboratory research and bedside application, ensuring that the latest scientific discoveries translate into real-world clinical improvements.

🌍 IMPACT AND INFLUENCE:

Dr. Ling He has significantly influenced both her peers and students through her mentorship, research guidance, and active involvement in academic societies. Her work has contributed to:

  • Improved clinical outcomes

  • Refined patient management protocols

  • Enhanced medical education at Nanchang University

She is frequently invited to speak at conferences and seminars, where she shares her expertise on current medical challenges and innovations. Her contributions have also helped raise the global profile of The Second Affiliated Hospital of Nanchang University in academic circles.

📚 ACADEMIC CITES:

Dr. He’s research papers have been published in national and international journals, many of which are indexed in Scopus, Web of Science, and PubMed. Her work is often cited by researchers in:

  • Clinical medicine

  • Nursing

  • Hospital management

  • Public health

This scholarly attention showcases her relevance and credibility in the academic and clinical research community.

🌟 LEGACY AND FUTURE CONTRIBUTIONS:

Assoc. Prof. Dr. Ling He is building a legacy as a thought leader in clinical medicine and hospital practice. Her future goals include:

  • Expanding international collaborations

  • Developing new models of patient-centered care

  • Training the next generation of clinicians and researchers

  • Publishing high-impact research in global medical journals

Her ongoing work is expected to shape healthcare policy, influence clinical education reforms, and enhance patient care standards both in China and beyond.

📝 OTHER IMPORTANT HIGHLIGHTS:

  • Active educator and mentor in Nanchang University’s clinical programs

  • Collaborative contributor to multi-hospital research networks

  • Advocate for innovation in healthcare systems

  • Works at the intersection of clinical practice and academic research

🌐CONCLUSION:

Assoc. Prof. Dr. Ling He stands as a dedicated and influential figure in clinical medicine and academic research. Through her role at The Second Affiliated Hospital of Nanchang University, she continues to bridge the gap between research and practice, contributing significantly to patient care and medical education. Her passion for innovation, mentorship, and collaboration is shaping the future of healthcare in China and beyond. As she advances in her career, Dr. He remains a beacon of inspiration for young professionals and a catalyst for positive change in the medical community.

TOP NOTABLE PUBLICATION

Joint assessment of abdominal obesity and non-traditional lipid parameters for primary prevention of cardiometabolic multimorbidity: insights from the China health and retirement longitudinal study 2011–2018

Authors: H. Lai, Y. Tu, C. Liao, L. He, J. Li

Journal: Cardiovascular Diabetology

Year: 2025

Sveeta Badiani | Aortic Stenosis | Best Research Article Award

Published on by Cardiology and Cardiovascular Medicine

Dr. Sveeta Badiani | Aortic Stenosis | Best Research Article Award

Xianhong Ou | Cardiovascular Pharmacology | Best Researcher Award

Published on by Cardiology and Cardiovascular Medicine

Dr. Xianhong Ou | Cardiovascular Pharmacology | Best Researcher Award

Mohammed Ahmed Akkaif | Cardiovascular Pharmacology | Best Researcher Award

Published on by Cardiology and Cardiovascular Medicine

Dr. Mohammed Ahmed Akkaif | Cardiovascular Pharmacology | Best Researcher Award

Dr. Mohammed Ahmed Akkaif, Fudan University, China

Dr. Mohammed Ahmed Akkaif is a Postdoctoral Researcher in the Department of Cardiology at Fudan University, China. He earned his Ph.D. in Clinical Pharmacy from Universiti Sains Malaysia in 2023, specializing in precision medicine, pharmacogenetics, and cardiology. A Young Ambassador for the European Association of Preventive Cardiology (2022–2024), he has published 34 peer-reviewed articles, with 29 indexed in SCI, and has over 2,179 citations. Recognized with the Young Researchers Award (ESC Asia 2022), he is a reviewer for 50+ high-impact journals. His research focuses on optimizing antithrombotic drug therapies through pharmacometabolomics for personalized cardiovascular treatment.

AUTHOR PROFILE

Scopus Profile

Orcid Profile

Google Scholar Profile

🎓EARLY ACADEMIC PURSUITS:

Dr. Mohammed Ahmed Akkaif began his academic journey with a strong foundation in Clinical Pharmacy at Universiti Sains Malaysia, where he completed his Doctor of Philosophy (PhD) in July 2023. During his PhD, he focused on the intersection of clinical pharmacy and biotechnology, gaining expertise in personalized and precision medicine. His academic accomplishments included publishing 10 articles (8 in SCI Q1 and Q2 journals) and presenting at six international conferences. This period also saw him design innovative approaches to enhance antithrombotic drug treatment, particularly through CYP2C19 genotype-guided antiplatelet therapy.

💼PROFESSIONAL ENDEAVORS:

Currently, Dr. Akkaif serves as a Postdoctoral Researcher in the Department of Cardiology at Fudan University’s Qingpu Branch of Zhongshan Hospital, China. His role involves leading advanced research in cardiovascular medicine, with a specialized focus on the clinical application of personalized medicine in cardiology. Additionally, he has served as a Young Ambassador for the European Association of Preventive Cardiology (EAPC) from 2022 to 2024, demonstrating his commitment to advancing heart health on a global scale. He has also contributed his expertise to several prestigious journals, with over 50 reviews in high-impact journals such as Journal of the American Heart Association and Arteriosclerosis, Thrombosis, and Vascular Biology.

🔬CONTRIBUTIONS AND RESEARCH FOCUS ON CARDIOVASCULAR PHARMACOLOGY:

Dr. Akkaif’s research is primarily focused on pharmacogenetics and pharmacometabolomics, with a goal of improving personalized treatment strategies in cardiology. His work delves into the optimization of antithrombotic drug therapies through genetic and metabolic profiling, which holds the potential to revolutionize treatment protocols, making them more tailored to individual patient profiles. His research also bridges the gap between clinical pharmacy and biotechnology, aiming to develop more effective, individualized approaches to cardiovascular health.

🌍IMPACT AND INFLUENCE:

Dr. Akkaif’s contributions have already made a significant impact on both academic research and the practical application of precision medicine. He has been honored with the Young Researchers Award at the 2022 ESC Asia Conference in Singapore, highlighting his early recognition in the field. His research has also led to the publication of 34 peer-reviewed articles, with 29 of them indexed in SCI (Clarivate), reflecting his growing influence in the field of cardiovascular pharmacology. His work has contributed to advancing the understanding of genetic factors in drug response, and his findings are regularly cited by researchers and clinicians alike.

📚ACADEMIC CITATIONS AND RECOGNITION:

Dr. Akkaif’s publications have earned him considerable academic recognition, with a cumulative citation count of 2,179 as of now. This citation count reflects the profound influence his work has had on the scientific community, particularly in the areas of pharmacogenetics, pharmacometabolomics, and cardiology. His ability to produce impactful, high-quality research is evident through his consistent presence in top-tier journals, where his findings continue to shape the discourse on personalized medicine.

🌟LEGACY AND FUTURE CONTRIBUTIONS:

As Dr. Akkaif continues his postdoctoral work at Fudan University, his future contributions are poised to expand on his research in precision medicine and cardiology. Given his accomplishments thus far, his research promises to lead to more personalized treatment options for cardiovascular diseases, potentially transforming clinical practices and improving patient outcomes globally. His ongoing efforts in understanding the genetic and metabolic factors influencing drug efficacy will likely place him at the forefront of the personalized medicine movement, paving the way for future innovations in the medical field.

🏆KEY AWARDS AND HONORS:

  • Young Researchers Award at the 2022 ESC Asia Conference (Singapore)

  • Second Prize for the Young Investigator Award at the ESC Asia Congress in Singapore 2022

  • Young Ambassador of the European Association of Preventive Cardiology (EAPC) (2022–2024)

  • Reviewing Excellence for over 50 high-impact SCI Q1 and Q2 journals

🌍CONCLUSION:

Dr. Mohammed Ahmed Akkaif’s groundbreaking research in precision medicine and cardiology continues to shape the future of personalized healthcare. With a strong academic background, numerous publications, and recognition through prestigious awards, his work is making significant contributions to improving cardiovascular treatments. His role as a Young Ambassador for the European Association of Preventive Cardiology further highlights his dedication to global health. As he advances his postdoctoral research at Fudan University, Dr. Akkaif’s future endeavors hold the potential to revolutionize clinical practices, particularly in pharmacogenetics and pharmacometabolomics, ensuring more effective and individualized patient care.

TOP NOTABLE PUBLICATIONS:

Global incidence, prevalence, years lived with disability (YLDs), disability-adjusted life-years (DALYs), and healthy life expectancy (HALE) for 371 diseases and injuries in …

Authors: AJ Ferrari, DF Santomauro, A Aali, YH Abate, C Abbafati, H Abbastabar, …

Journal: The Lancet

Year: 2024

Global burden and strength of evidence for 88 risk factors in 204 countries and 811 subnational locations, 1990–2021: a systematic analysis for the Global Burden of Disease …

Authors: M Brauer, GA Roth, AY Aravkin, P Zheng, KH Abate, YH Abate, C Abbafati, …

Journal: The Lancet

Year: 2024

Global burden of 288 causes of death and life expectancy decomposition in 204 countries and territories and 811 subnational locations, 1990–2021: a systematic analysis for the …

Authors: The Lancet

Year: 2024

Global burden of bacterial antimicrobial resistance 1990–2021: a systematic analysis with forecasts to 2050

Authors: M Naghavi, SE Vollset, KS Ikuta, LR Swetschinski, AP Gray, EE Wool, …

Journal: The Lancet

Year: 2024

Burden of disease scenarios for 204 countries and territories, 2022–2050: a forecasting analysis for the Global Burden of Disease Study 2021

Authors: SE Vollset, HS Ababneh, YH Abate, C Abbafati, R Abbasgholizadeh, …

Journal: The Lancet

Year: 2024

Global, regional, and national burden of stroke and its risk factors, 1990–2021: a systematic analysis for the Global Burden of Disease Study 2021

Authors: VL Feigin, MD Abate, YH Abate, S Abd ElHafeez, F Abd-Allah, …

Journal: The Lancet Neurology

Year: 2024

Global fertility in 204 countries and territories, 1950–2021, with forecasts to 2100: a comprehensive demographic analysis for the Global Burden of Disease Study 2021

Authors: NV Bhattacharjee, AE Schumacher, A Aali, YH Abate, R Abbasgholizadeh, …

Journal: The Lancet

Year: 2024

The Role of Genetic Polymorphism and Other Factors on Clopidogrel Resistance (CR) in an Asian Population with Coronary Heart Disease (CHD)

Authors: MA Akkaif, NAA Daud, A Sha’aban, ML Ng, MAS Abdul Kader, DA Noor

Journal: Molecules

Year: 2021

A review of the effects of ticagrelor on adenosine concentration and its clinical significance

Authors: MA Akkaif, ML Ng, MASA Kader, NAA Daud, A Sha’aban, B Ibrahim

Journal: Pharmacological Reports

Year: 2021

National-level and state-level prevalence of overweight and obesity among children, adolescents, and adults in the USA, 1990–2021, and forecasts up to 2050

Authors: M Ng, X Dai, RM Cogen, M Abdelmasseh, A Abdollahi, A Abdullahi, …

Journal: The Lancet

Year: 2024

 

Xiaodi Tang | Cardiovascular Medicine | Best Researcher Award

Published on by Cardiology and Cardiovascular Medicine

Dr. Xiaodi Tang | Cardiovascular Medicine | Best Researcher Award

Yongsub Choi | Cardiovascular Disease | Best Researcher Award

Published on by Cardiology and Cardiovascular Medicine

Dr. Yongsub Choi | Cardiovascular Disease | Best Researcher Award

Dr. Yongsub Choi, Bellin Memorial Hospital, South Korea

Dr. Yongsub Choi is a dedicated internal medicine physician at Bellin Memorial Hospital, Green Bay, WI. He completed his MBBS (Summa Cum Laude) from Harbin Medical University, China, and an Internal Medicine Residency at BronxCare Health System, NYC. With extensive research experience in cardiology, nephrology, and gastroenterology, he has contributed to advancements in ventricular arrhythmia, atrial fibrillation, and liver recovery. Dr. Choi’s diverse background includes leadership roles, international medical practice, and teaching. His commitment to patient care, research, and global healthcare improvement makes him a distinguished figure in the field of internal medicine.

AUTHOR PROFILE

Scopus Profile

Orcid Profile

🎓EARLY ACADEMIC PURSUITS:

Dr. Yongsub Choi’s academic journey is marked by excellence and dedication. He earned his Bachelor of Medicine, Bachelor of Surgery (MBBS) from Harbin Medical University, China, graduating Summa Cum Laude. His academic excellence was evident throughout his studies, securing the First Prize Scholarship multiple times (2008-2009, 2011-2014). Prior to his medical education, he pursued Theology and Anthropology at Don Bosco Center of Studies, Manila, Philippines, where he graduated Cum Laude. Additionally, he completed his Bachelor of Philosophy (B.Ph) at Gwangju Catholic University, South Korea.

🏥PROFESSIONAL ENDEAVORS:

Dr. Choi has built a dynamic and diverse career in internal medicine, research, and leadership. Currently, he serves as a Hospitalist at the Department of Internal Medicine, Apogee Physicians, Bellin Memorial Hospital, Green Bay, WI (April 2023 – Present). His previous medical roles include:

  • Resident Physician at BronxCare Health System, NYC, USA (Feb 2020 – Jan 2023)
  • Locum Intern at Savanna-La-Mar Public General Hospital, Jamaica (Jan – June 2019)

In addition to his medical career, he held leadership roles such as:

  • Acting Executive Director (Apr 2007 – Feb 2008) at International Cooperational Technical High School, Yanji, China
  • English Teacher at Baosigao Technical High School, Taiwan
  • Assistant Parish Priest at Gurosamdong Parish, South Korea
  • Private Soldier in the Republic of Korea Army, Cheolwon, South Korea

🔬CONTRIBUTIONS AND RESEARCH FOCUS ON CARDIOVASCULAR DISEASE:

Dr. Choi’s contributions to medical research have significantly impacted the fields of cardiology, nephrology, and gastroenterology. His research roles include:

Research Assistant – First Affiliated Hospital of Harbin Medical University, China

  • Investigated modulation of activated astrocytes in the hypothalamus paraventricular nucleus to prevent ventricular arrhythmia during acute myocardial infarction (July 2019 – Jan 2020).
  • Explored sonodynamic therapy for atrial fibrillation (AF) using a rabbit model (Mar 2017 – June 2018).
  • Studied mesenchymal stem cells with enhanced Bcl-2 expression to improve liver recovery in hepatic cirrhosis (July 2014 – Feb 2017).

Research Scholar – Albert Einstein College of Medicine, Bronx, NY

  • Focused on nephrology-related research under Dr. Victor L. Schuster, M.D. (June 2018 – Dec 2018).

🌍IMPACT AND INFLUENCE:

Dr. Choi’s work bridges clinical practice, academia, and international healthcare initiatives. His contributions extend beyond medical practice to mentorship, leadership, and medical education. His experience in multiple countries (USA, China, Jamaica, Taiwan, South Korea, and the Philippines) highlights his global perspective on healthcare and medical research.

🏅ACADEMIC CITES AND HONORS:

Dr. Choi has received numerous awards and recognitions:
Graduated Summa Cum Laude – Harbin Medical University (2014)
First Prize Scholarship (Top Student) – Harbin Medical University (2008-09, 2011-14)
Secretary of Class of 2008 – Harbin Medical University (2012-2014)
Cum Laude – Don Bosco Center of Studies, Manila, Philippines (2001)

🚀LEGACY AND FUTURE CONTRIBUTIONS:

Dr. Choi continues to shape the future of internal medicine and medical research. His extensive experience in cardiology, nephrology, and gastroenterology positions him as a key contributor to advancements in patient care and treatment methodologies. Moving forward, he aims to:

Enhance clinical excellence through evidence-based medicine.
Contribute to medical education and mentorship.
Advance research in cardiovascular and metabolic diseases.
Improve healthcare accessibility and quality in underprivileged regions.

 🌟CONCLUSION:

Dr. Yongsub Choi’s journey is a testament to dedication, excellence, and global impact in internal medicine and research. His expertise in cardiology, nephrology, and gastroenterology has contributed to significant advancements in patient care. With a strong foundation in clinical practice, leadership, and education, he continues to inspire future medical professionals. His commitment to evidence-based medicine, mentorship, and international healthcare development reflects his passion for improving lives worldwide. As he moves forward, Dr. Choi remains a trailblazer in internal medicine, striving for innovation and excellence in patient care and medical research.

TOP NOTABLE PUBLICATION

Probability assessment of pulmonary embolism using clinical and laboratory variables in hospitalized patients: A single-center, retrospective observational study

Authors: Y. Choi, Yongsub; N. Prasai, Neeti; T. Bhatt, Tanushree; A. Latif, Amber; M. Khaja, Misbahuddin

Journal: Thrombosis Update

Year: 2024

Yan Pan | Kawasaki disease | Best Researcher Award

Published on by Cardiology and Cardiovascular Medicine

Mr. Yan Pan | Kawasaki disease | Best Researcher Award

Mr. Yan Pan, The First Affiliated Hospital of Yangtze University, China

Mr. Yan Pan is a distinguished pediatrician at The First Affiliated Hospital of Yangtze University, China, specializing in Kawasaki disease. He serves as Deputy Chief Physician of Pediatrics and Chief Expert of the Kawasaki Disease MDT Team. A Fellow of the Royal Society of Arts and Crafts (RSA, UK), he is Deputy Editor-in-Chief of the International Journal of Pediatrics (2023). With 10 SCI-indexed publications, he has led multiple research projects and contributed to China’s 2023 Kawasaki Disease Treatment Guidelines. Recognized with awards for pediatric research excellence, he continues to advance pediatric infectious disease diagnosis and treatment globally.

AUTHOR PROFILE

Google Scholar Profile

🎓EARLY ACADEMIC PURSUITS:

Mr. Yan Pan pursued a strong academic foundation in pediatrics, focusing on childhood diseases and immunological disorders. His passion for medical research led him to specialize in Kawasaki disease, a rare but serious pediatric illness. His early education and training laid the groundwork for his later contributions to pediatric medicine and innovative treatments.

🏥PROFESSIONAL ENDEAVORS:

Currently, Mr. Yan Pan serves as the Deputy Chief Physician of Pediatrics at The First Affiliated Hospital of Yangtze University in China. He is the Chief Expert of the Kawasaki Disease MDT Team, where he plays a crucial role in diagnosing and treating Kawasaki disease. In 2023, he was appointed Deputy Editor-in-Chief of the International Journal of Pediatrics, contributing significantly to the field through editorial leadership and research dissemination.

🔍CONTRIBUTIONS AND RESEARCH FOCUS ON KAWASAKI DISEASE:

Mr. Yan Pan has been actively involved in numerous scientific research projects, including:

  • Hosting a project for the Hubei Pediatric Medical Alliance (2021), which received an excellent completion rating.
  • Leading two research projects in Jingzhou City, one of which won third prize in the Jingzhou City Natural Science Excellent Academic Paper Award (2020).
  • Contributing to a major research project at the Wuhan Science and Technology Bureau, which is currently ongoing.
  • Collaborating with the Kawasaki Disease Center at Chang Gung Memorial Hospital, Taiwan, to advance treatment protocols and research.

His research primarily focuses on pediatric infections and immunity, particularly Kawasaki disease, aiming to enhance diagnostic accuracy and treatment efficacy.

🌍IMPACT AND INFLUENCE:

His influence extends beyond clinical practice and research. He is recognized as:

  • A Fellow of the Royal Society of Arts and Crafts (RSA), UK.
  • A China National Knowledge Infrastructure (CNKI) Evaluation Expert.
  • An Expert of the China Pharmaceutical Innovation Industry Science and Technology Service Team for Science and Technology Innovation.

His expertise has shaped clinical guidelines and treatment protocols, directly impacting the pediatric community in China and beyond.

📚ACADEMIC CITATIONS AND RECOGNITION:

  • 10 SCI-indexed articles published as first author or corresponding author.
  • Awarded “Best Researcher” in Pediatric Infection and Immunity (2023), organized by Science Father.
  • Recognized as an Excellent Scientific and Technological Worker at the Kawasaki Disease Diagnosis and Treatment Research Center in Shaanxi Province (2023).
  • Winner of the Best Outstanding Paper of the Year (2023) by Discussion of Clinical Cases Magazine.

🚀LEGACY AND FUTURE CONTRIBUTIONS:

Mr. Yan Pan’s lasting contributions to pediatric medicine include his role in compiling the “Evidence-Based Treatment Guidelines for Kawasaki Disease in Chinese Children (2023 Edition)”. His continued research and dedication to improving diagnostic and treatment methodologies ensure that his impact will be felt for generations to come.

His future focus remains on enhancing Kawasaki disease treatment, expanding research collaborations, and mentoring the next generation of pediatricians to advance medical knowledge and patient care.

🌟CONCLUSION:

Mr. Yan Pan is a leading pediatrician dedicated to advancing the diagnosis and treatment of Kawasaki disease in children. His contributions to research, clinical practice, and medical guidelines  have significantly improved pediatric healthcare. As a renowned expert and mentor , he continues to shape the future of pediatric infectious disease treatment. With numerous awards, publications, and leadership roles , his impact extends beyond China to the global medical community . Through his dedication and innovation, Mr. Yan Pan remains a driving force in ensuring better health outcomes for children worldwide.

TOP NOTABLE PUBLICATIONS

Title: Anal swab findings in an infant with COVID-19
Authors: Q Fan, Y Pan, Q Wu, S Liu, X Song, Z Xie, Y Liu, L Zhao, Z Wang, Y Zhang, …
Journal: Pediatric Investigation
Year: 2020

Title: The M235T polymorphism in the angiotensinogen gene and myocardial infarction risk: A meta-analysis
Authors: YJ Wang, Y Pan
Journal: Journal of the Renin-Angiotensin-Aldosterone System
Year: 2014

Title: Angiotensin-converting enzyme insertion/deletion polymorphism and susceptibility to Kawasaki disease: a meta-analysis
Authors: Y Pan, H Lu
Journal: African Health Sciences
Year: 2017

Title: Treatment of immunoglobulin-resistant Kawasaki disease: a Bayesian network meta-analysis of different regimens
Authors: Y Pan, Q Fan, L Hu
Journal: Frontiers in Pediatrics
Year: 2023

Title: Identification of potential core genes in immunoglobulin-resistant Kawasaki disease using bioinformatics analysis
Authors: Y Pan, Q Fan
Journal: Critical Reviews™ in Eukaryotic Gene Expression
Year: 2020

Title: Guideline for the diagnosis and treatment of incomplete Kawasaki disease in children in China
Authors: F Jiao, Y Pan, Z Du, F Deng, X Yang, H Wang, J Shen, W Xiang, Z Mu, …
Journal: BMC Pediatrics
Year: 2024

Title: The role of procalcitonin for predicting Kawasaki disease
Authors: Y Pan, Q Fan
Journal: Fetal and Pediatric Pathology
Year: 2022

Title: Clostridium symbiosum sepsis diagnosed using next-generation sequencing in a 2-year-old child: a case report
Authors: Y Pan, Q Fan
Journal: Fetal and Pediatric Pathology
Year: 2023

Title: Application of artificial intelligence in the diagnosis and treatment of Kawasaki disease
Authors: Y Pan, FY Jiao
Journal: World Journal of Clinical Cases
Year: 2024

Title: Relationship between Kawasaki disease and abdominal pain
Authors: Y Pan, FY Jiao
Journal: World Journal of Clinical Cases
Year: 2024

Yao An | Thrombosis | Best Researcher Award

Published on by Cardiology and Cardiovascular Medicine

Mr. Yao An | Thrombosis | Best Researcher Award